FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2467632157> ?p ?o ?g. }

• W2467632157 endingPage "230" @default.
• W2467632157 startingPage "223" @default.
• W2467632157 abstract "OBJECTIVE: To evaluate the effects of microRNA-21 (miR-21) in peripheral blood mononuclear cells (PBMC) in the diagnosis and prognosis of prostate cancer (PCa). METHODS: Proved by pathologic biopsy, 92 patients diagnosed with PCa and also underwent resection operation and 85 patients with benign pr ostatic hyperplasia (BPH) were selected in this study, as well as 97 healthy volunteers were chosen as the control group. PBMC were extracted to examine the relative expression of miR-21 by real time reverse transcriptase-polymerase chain reaction (RT-PCR). The relative operating characteristic (ROC) curves were drew to analyze the diagnosis value of PCa. The survival function curves were made by Kaplan-Meier method to show the miR-21 expression levels of PCa patients. The Log-rank test was adopted to compare the differences among the different groups. The Cox proportional hazard risk regression analysis was used to screen the independent factors affected the PCa patients. RESULTS: The expression levels of miR-21 in PCa group were increased compared to BPH and control group (P < 0.05). The expression of miR-21 was significantly correlated with the Gleason score, clinical stages, bone metastasis and tumor recurrence (all P < 0.05). ROC curves demonstrated that the area under the curve of PCa and BPH distinguished by the miR-21 were 0.974 and 95% confidence intervals (95% CI) were 0.956∼ 0.993. The sensitivity and specificity were 93.5% and 92.9%. ROC curves demonstrated that the area under the curve of PCa and control group distinguished by the miR-21 were 0.984 and 95% CI were 0.972∼ 0.997. The sensitivity and specificity were 94.6% and 92.8%. The results of Kaplan-Meier Method demonstrated that the miR-21 expression levels were related to the prognosis of PCa (all P < 0.05). The results of the COX analysis suggested that the miR-21 expression level, tumor recurrence and bone metastasis could be the independent factors affected the prognosis of PCa patients (all P < 0.05). CONCLUSION: miR-21 is highly expressed in the PCa patients, which could be the molecule biomarker of diagnosis and prognosis of PCa." @default.
• W2467632157 created "2016-07-22" @default.
• W2467632157 creator A5002616304 @default.
• W2467632157 creator A5003850660 @default.
• W2467632157 creator A5006415782 @default.
• W2467632157 creator A5016291949 @default.
• W2467632157 creator A5032331494 @default.
• W2467632157 creator A5040711000 @default.
• W2467632157 creator A5048587034 @default.
• W2467632157 creator A5060404389 @default.
• W2467632157 creator A5065771969 @default.
• W2467632157 creator A5076768386 @default.
• W2467632157 date "2016-08-03" @default.
• W2467632157 modified "2023-09-24" @default.
• W2467632157 title "MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer" @default.
• W2467632157 cites W1558536753 @default.
• W2467632157 cites W1964453634 @default.
• W2467632157 cites W1966434915 @default.
• W2467632157 cites W1974610104 @default.
• W2467632157 cites W1983145936 @default.
• W2467632157 cites W2001994418 @default.
• W2467632157 cites W2003473186 @default.
• W2467632157 cites W2013498844 @default.
• W2467632157 cites W2032800737 @default.
• W2467632157 cites W2035933918 @default.
• W2467632157 cites W2037044064 @default.
• W2467632157 cites W2037089056 @default.
• W2467632157 cites W2046409229 @default.
• W2467632157 cites W2047019054 @default.
• W2467632157 cites W2049700579 @default.
• W2467632157 cites W2051740071 @default.
• W2467632157 cites W2083365530 @default.
• W2467632157 cites W2084637523 @default.
• W2467632157 cites W2096528675 @default.
• W2467632157 cites W2096650295 @default.
• W2467632157 cites W2097226448 @default.
• W2467632157 cites W2108244696 @default.
• W2467632157 cites W2112187582 @default.
• W2467632157 cites W2115093090 @default.
• W2467632157 cites W2120092803 @default.
• W2467632157 cites W2139966272 @default.
• W2467632157 cites W2145848169 @default.
• W2467632157 cites W2151834630 @default.
• W2467632157 cites W2175737380 @default.
• W2467632157 doi "https://doi.org/10.3233/cbm-160634" @default.
• W2467632157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27434290" @default.
• W2467632157 hasPublicationYear "2016" @default.
• W2467632157 type Work @default.
• W2467632157 sameAs 2467632157 @default.
• W2467632157 citedByCount "29" @default.
• W2467632157 countsByYear W24676321572017 @default.
• W2467632157 countsByYear W24676321572018 @default.
• W2467632157 countsByYear W24676321572019 @default.
• W2467632157 countsByYear W24676321572020 @default.
• W2467632157 countsByYear W24676321572021 @default.
• W2467632157 countsByYear W24676321572022 @default.
• W2467632157 countsByYear W24676321572023 @default.
• W2467632157 crossrefType "journal-article" @default.
• W2467632157 hasAuthorship W2467632157A5002616304 @default.
• W2467632157 hasAuthorship W2467632157A5003850660 @default.
• W2467632157 hasAuthorship W2467632157A5006415782 @default.
• W2467632157 hasAuthorship W2467632157A5016291949 @default.
• W2467632157 hasAuthorship W2467632157A5032331494 @default.
• W2467632157 hasAuthorship W2467632157A5040711000 @default.
• W2467632157 hasAuthorship W2467632157A5048587034 @default.
• W2467632157 hasAuthorship W2467632157A5060404389 @default.
• W2467632157 hasAuthorship W2467632157A5065771969 @default.
• W2467632157 hasAuthorship W2467632157A5076768386 @default.
• W2467632157 hasConcept C104317684 @default.
• W2467632157 hasConcept C10515644 @default.
• W2467632157 hasConcept C121608353 @default.
• W2467632157 hasConcept C126322002 @default.
• W2467632157 hasConcept C137061746 @default.
• W2467632157 hasConcept C143998085 @default.
• W2467632157 hasConcept C145059251 @default.
• W2467632157 hasConcept C202751555 @default.
• W2467632157 hasConcept C207103383 @default.
• W2467632157 hasConcept C2777562237 @default.
• W2467632157 hasConcept C2780192828 @default.
• W2467632157 hasConcept C2781197716 @default.
• W2467632157 hasConcept C44249647 @default.
• W2467632157 hasConcept C48023723 @default.
• W2467632157 hasConcept C50382708 @default.
• W2467632157 hasConcept C55493867 @default.
• W2467632157 hasConcept C58471807 @default.
• W2467632157 hasConcept C71924100 @default.
• W2467632157 hasConcept C76318530 @default.
• W2467632157 hasConcept C86803240 @default.
• W2467632157 hasConcept C90924648 @default.
• W2467632157 hasConceptScore W2467632157C104317684 @default.
• W2467632157 hasConceptScore W2467632157C10515644 @default.
• W2467632157 hasConceptScore W2467632157C121608353 @default.
• W2467632157 hasConceptScore W2467632157C126322002 @default.
• W2467632157 hasConceptScore W2467632157C137061746 @default.
• W2467632157 hasConceptScore W2467632157C143998085 @default.
• W2467632157 hasConceptScore W2467632157C145059251 @default.
• W2467632157 hasConceptScore W2467632157C202751555 @default.
• W2467632157 hasConceptScore W2467632157C207103383 @default.

• next